Metraipolis › archive › dc_db484a2dfdfa

Safety Assessment of Glucagon-Like Peptide 1 Receptor Agonists Based on the FAERS Database: Focus on Tumorigenic Risk in Subpopulations — Europe PMC PMID:41861108

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41861108
DOI
10.1155/jdr/8893769
License (as archived)
solo-consultazione
Archived
2026-11-07T05:01:13.228Z
SHA-256 of the archived text
3a7bed420f18e8b3ea7a761465eef4c353babc77b4470a4c730cbf842d4beb56
Stable URL of this page
https://metraipolis.com/documento/dc_db484a2dfdfa

How to cite

Safety Assessment of Glucagon-Like Peptide 1 Receptor Agonists Based on the FAERS Database: Focus on Tumorigenic Risk in Subpopulations — Europe PMC PMID:41861108 — Europe PMC (en), https://europepmc.org/article/MED/41861108 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_db484a2dfdfa (Metraipolis archive dc_db484a2dfdfa, sha256 3a7bed420f18e8b3ea7a761465eef4c353babc77b4470a4c730cbf842d4beb56)
BibTeX
@misc{dcdb484a2dfdfa,
  title = {Safety Assessment of Glucagon-Like Peptide 1 Receptor Agonists Based on the FAERS Database: Focus on Tumorigenic Risk in Subpopulations — Europe PMC PMID:41861108},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41861108},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_db484a2dfdfa; sha256 3a7bed420f18e8b3ea7a761465eef4c353babc77b4470a4c730cbf842d4beb56},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41861108. Agents can read the archived copy with the MCP tool read_document.